Dr Sally Argyle
Following my qualification as a veterinary surgeon I spent a short period of time working in a mixed mainly small animal practice. I was then able to concentrate on small animal internal medicine (with a particular interest in cardiology) at Glasgow University Veterinary School for a further two years. I then moved into a more research-focused role to complete a PhD entitled Canine Vasculature: a study of alpha1-adrenoreceptors and heart failure; in the Institute of Biomedical and Life Sciences at Glasgow University. Subsequently I took up the position of Lecturer in Veterinary Pharmacology back at the Veterinary School in Glasgow. During this time I continued to be interested in cardiovascular disease but also became interested in the use of antimicrobials and particularly in the rational use of antimicrobials and antimicrobial resistance. I am currently Senior Lecturer in Veterinary Pharmacology and Therapeutics at the University of Edinburgh’s Royal (Dick) School of Veterinary Studies. This is a post that I have held since May 2006.
I am responsble for teaching veterinary pharmacology and therapeutics to undergaduate veterinary students throughout the BVM&S programme. I am also particularly interested in student assessment and chair the Assessment Executive for the School. I am also Director of the third year of the BVM&S programme.
Continuing professional development delivery to the veterinary profession is also something in which I am actively involved.
Bachelor of Veterinary Medicine, School of Veterinary Medicine, University College Dublin Doctor of Veterinary Medicine, University of Glasgow Canine Vasculature: A study of alpha1-adrenoreceptors and heart failure
Certificate in Small Animal Cardiology, Cert SAC
Responsibilities & affiliations
Admissions, School/Campus Administration
Director and Associate Dean for Admissions (undergraduate)
Director of Year 3 of the BVM&S programme
Chair of the Assessment Executive
Current research interestsI have continued both a clinical and research interest in antimicrobial resistance and from a research perspective am involved in research into multidrug resistant E. coli in companion animal species. This is currently the topic of a 4 year PhD studentship exploring the molecular epidemiology of these organisms. I am also involved in cardiovascular research and currently I am working on a collaborative project using 2 and 3D models of mitral valve disease in dogs to explore the pathophysiology of this disease and identify potential therapeutic targets.
A pilot study of the in vitro antimicrobial activity and in vivo residual activity of chlorhexidine and acetic acid/boric acid impregnated cleansing wipes
Antibiotic prophylaxis in veterinary cancer chemotherapy: a review and recommendations.
Convergence of plasmid architectures drives emergence of multi-drug resistance in a clonally diverse Escherichia coli population from a veterinary clinical care setting
Selection of veterinary students: does the interview do what we think and what we want?
A perspective from Edinburgh: When it comes to student selection, does the interview do what we think and what we want?
Phylogenomic approaches to determine the zoonotic potential of Shiga toxin-producing Escherichia coli (STEC) isolated from Zambian dairy cattle
Type III Secretion-Dependent Sensitivity of Escherichia coli O157 to Specific Ketolides
Prophylactic use of antimicrobials in surgical pig models; a literature review (2012-2014)
The long-acting COX-2 inhibitor mavacoxib (Trocoxil (TM)) has anti-proliferative and pro-apoptotic effects on canine cancer cell lines and cancer stem cells in vitro
Multidrug-resistant Escherichia coli from canine urinary tract infections tend to have commensal phylotypes, lower prevalence of virulence determinants and ampC-replicons